Keep playing while I browse
Allyson Mullen examines how QMSR is changing FDA’s approach to risk, inspections, quality agreements, and accountability across the quality system.
Allyson Mullen examines how QMSR is changing FDA’s approach to risk, inspections, quality agreements, and accountability across the quality system.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.